Intellectual Property

The intellectual property assets of Accellta include a portfolio of patents pertaining to novel techniques and products, including:

• Pluripotent stem Cell culturing
• Human foreskin-derived feeder cells
• Growth media for feeder-free culturing of hPSC
• Stem Cell expansion in suspension
• Stem Cell culturing as single-cells in bioreactors
• Stem-Cell controlled differentiation
• Medium formulation